New York University

Citibank, N.a.

American Biosciences, Inc.

The United States of America As Represented by the Secretary of

The United States of America As Represented by the Department of Health

National Institutes of Health

Peter Huang

Paul L Huang

Sylvia Lee-Huang

Philip L Huang

Hao-Chia Chen

Yan Liu

Chuan Li

Hsiang-fu Kung

Alicia Wang

Henry I Huang

Jim B Adams

Peter L Nara

James Boyd Adams

Systems and methods for a programming language-agnostic data modeling platform that is both less resource intensive and scalable. Additionally, the programming language-agnostic data modeling platform allows for advanced analytics to be run on descriptions of the known logical data models, to generate data offerings describing underlying data, and to easily format data for compatibility with artificial intelligence systems. The systems and methods use a supplemental data structure that comprises logical data modeling metadata, in which the logical data modeling metadata describes the logical data model in a common, standardized language. For example, the logical data modeling metadata may comprise a transformer lineage of the logical data model.

Resolving dataset corruption of transferred datasets using programming language-agnostic data modeling platforms

Systems and methods for generating data transfers using programming language-agnostic data modeling platforms

A new protein, termed TAP 29, obtainable from the root tuber of the plant Trichosanthes kirilowii or produced by recombinant means is useful for treating HIV infections or tumors. In treating HIV infections, the protein is administered alone or in conjunction with conventional AIDS therapies. Also provided are processes for purifying the protein, DNA sequences encoding the protein, hosts expressing the protein, recombinant DNA methods for expressing the protein, and antibodies specific for the protein.

Anti-HIV protein, TAP 29, from tricosanthes, DNA coding therefor and

A protein, in particular MAP 30, obtainable from both the fruit and seeds of Momordica charantia or produced by recombinant means useful for treating tumors and HIV infections is disclosed. In treating HIV infections, the protein is administered alone or in conjunction with conventional AIDS therapies. Also provided are processes for purifying the protein, DNA sequences encoding the protein, and recombinant DNA methods for expressing the protein.

Plant protein useful for treating tumors and HIV infection

New proteins, termed GAP 31, obtainable from the seeds of Gelonium multiflorum, and DAP 30 and DAP 32, obtainable from the leaves or seeds of Dianthus caryophyllus, or the above proteins produced by recombinant means, are useful for treating HIV infections. In treating HIV infections, the protein is administered alone or in conjunction with other anti-HIV therapeutics. Also provided are processes for purifying the proteins, DNA sequences encoding the proteins, hosts expressing the proteins, recombinant DNA methods for expressing the proteins, and antibodies specific for the proteins.

Anti-HIV proteins GAP 31, DAP 30 and DAP 32 and therapeutic uses thereof

Growing community of inventors

New York, NY, United States of America

Peter Huang